Becton, Dickinson and Company (BDX) Stock Analysis & Winston Score

Becton, Dickinson and Company (BD) makes medical supplies and devices used in hospitals, clinics, and labs around the world. Its core products include syringes, needles, catheters, diagnostic testing equipment, and drug delivery systems. BD is one of the largest medical device companies in the world and is a major supplier to healthcare systems, pharmaceutical companies, and blood banks. BD earns revenue by selling its products directly to hospitals and healthcare providers, as well as through long-term supply contracts with large health systems and governments. The company operates globally, with significant sales in North America, Europe, and Asia, and generates roughly $20 billion in annual revenue. Its moat comes from deep customer relationships, regulatory approvals that take years to obtain, and the high cost of switching suppliers in clinical settings. The main risk BD faces is its heavy debt load from past acquisitions, which limits financial flexibility and keeps returns on invested capital relatively low.